AAV with ALB(1.9) promoter driven EYFP
This AAV expresses EYFP driven by a liver ALB(1.9) promoter.
The ALB(1.9) is a synthetic promoter of ~1.9 Kb. It is based on the human Albumin promoter as well as several other regulatory elements. This synthetic promoter gives an extremely high level of long-term, liver-specific transgene expression that is 100-100 fold greater than that of the CMV promoter. For short-term (1-2 weeks post-injection into mouse liver), ALB(1.9) gives comparable expression relative to that of the CMV promoter. However, the expression level of the CMV promoter decreases 100-1000 fold from its peak level within 10-20 weeks of DNA administration whereas the ALB(1.9) promoter sustains its initial high level of expression for over 1 year. Compared to the regular ALB promoter, which is also commonly used for liver-specific transgene expression, the expression level from ALB(1.9) is about 10-100 fold greater.
YFP is the longest wavelength-emitting variants of Aequorea GFP. The enhanced version, EYFP, has become one of the brightest and most widely utilized of the fluorescent proteins with an Excitation/Emission spectrum centered around 514nm/527nm. Other fluorescent proteins with similar emission spectrums include Topaz, Venus, Citrine and mCitrine.
Ready-to-use AAV expressing EYFP driven by a liver ALB(1.9) promoter. Available in AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, AAV-DJ and other serotypes.